These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 3878728)

  • 1. Proton nuclear magnetic resonance study of the third component of complement: solution conformation of the carboxyl-terminal segment of C3a fragment.
    Muto Y; Fukumoto Y; Arata Y
    Biochemistry; 1985 Nov; 24(23):6659-65. PubMed ID: 3878728
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Solution conformation of carboxy-terminal fragments of the third component of human complement C3: proton nuclear magnetic resonance study of C3a, des-Arg-C3a, and C3a Arg69.
    Muto Y; Fukumoto Y; Arata Y
    J Biochem; 1987 Sep; 102(3):635-41. PubMed ID: 3501427
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proton nuclear magnetic resonance study of the solution conformation of C3a-Arg69, a 69-residue N-terminal fragment of the third component of complement.
    Muto Y; Inagaki F; Arata Y
    J Biochem; 1989 Feb; 105(2):330-7. PubMed ID: 2656667
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Secondary structure of complement component C3a anaphylatoxin in solution as determined by NMR spectroscopy: differences between crystal and solution conformations.
    Nettesheim DG; Edalji RP; Mollison KW; Greer J; Zuiderweg ER
    Proc Natl Acad Sci U S A; 1988 Jul; 85(14):5036-40. PubMed ID: 3260670
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 1H NMR studies of human C3a anaphylatoxin in solution: sequential resonance assignments, secondary structure, and global fold.
    Chazin WJ; Hugli TE; Wright PE
    Biochemistry; 1988 Dec; 27(26):9139-48. PubMed ID: 3266557
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Helical conformation at the carboxy-terminal portion of human C3a is required for full activity.
    Hoeprich PD; Hugli TE
    Biochemistry; 1986 Apr; 25(8):1945-50. PubMed ID: 3486674
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Conformational analysis of COOH-terminal segments of human C3a. Evidence of ordered conformation in an active 21-residue peptide.
    Lu ZX; Fok KF; Erickson BW; Hugli TE
    J Biol Chem; 1984 Jun; 259(12):7367-70. PubMed ID: 6610676
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proton nuclear magnetic resonance study on the dynamics of the conformation of the hinge segment of human G1 immunoglobulin.
    Ito W; Arata Y
    Biochemistry; 1985 Nov; 24(23):6467-74. PubMed ID: 4084533
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A proton nuclear magnetic resonance study of the conformation of bovine anaphylatoxin C5a in solution.
    Zarbock J; Gennaro R; Romeo D; Clore GM; Gronenborn AM
    FEBS Lett; 1988 Oct; 238(2):289-94. PubMed ID: 3262536
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The primary structure of porcine C3a anaphylatoxin.
    Corbin NC; Hugli TE
    J Immunol; 1976 Sep; 117(3):990-5. PubMed ID: 956663
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Purification and partial characterization of human and porcine C3a anaphylatoxin.
    Hugli TE; Vallota EH; Müller-Eberhard HJ
    J Biol Chem; 1975 Feb; 250(4):1472-8. PubMed ID: 803505
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proton nuclear magnetic resonance study of human plasma alpha-2-macroglobulin.
    Arakawa H; Muto Y; Arata Y; Ikai A
    Biochemistry; 1986 Nov; 25(22):6785-9. PubMed ID: 2432925
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High-resolution NMR studies of fibrinogen-like peptides in solution: structure of a thrombin-bound peptide corresponding to residues 7-16 of the A alpha chain of human fibrinogen.
    Ni F; Meinwald YC; Vásquez M; Scheraga HA
    Biochemistry; 1989 Apr; 28(7):3094-105. PubMed ID: 2742827
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High-resolution NMR studies of fibrinogen-like peptides in solution: structural basis for the bleeding disorder caused by a single mutation of Gly(12) to Val(12) in the A alpha chain of human fibrinogen Rouen.
    Ni F; Konishi Y; Bullock LD; Rivetna MN; Scheraga HA
    Biochemistry; 1989 Apr; 28(7):3106-19. PubMed ID: 2742828
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tertiary structure of human complement component C5a in solution from nuclear magnetic resonance data.
    Zuiderweg ER; Nettesheim DG; Mollison KW; Carter GW
    Biochemistry; 1989 Jan; 28(1):172-85. PubMed ID: 2784981
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of in vitro natural killer activity by the third component of complement: role for the C3a fragment.
    Charriaut C; Senik A; Kolb JP; Barel M; Frade R
    Proc Natl Acad Sci U S A; 1982 Oct; 79(19):6003-7. PubMed ID: 6985269
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human anaphylatoxin (C3a) from the third component of complement. Primary structure.
    Hugli TE
    J Biol Chem; 1975 Nov; 250(21):8293-301. PubMed ID: 1238393
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Conformation of cobrotoxin in aqueous solution as studied by nuclear magnetic resonance.
    Endo T; Inagaki F; Hayashi K; Miyazawa T
    Eur J Biochem; 1979 Dec; 102(2):417-30. PubMed ID: 43248
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High-resolution NMR studies of fibrinogen-like peptides in solution: interaction of thrombin with residues 1-23 of the A alpha chain of human fibrinogen.
    Ni F; Konishi Y; Frazier RB; Scheraga HA; Lord ST
    Biochemistry; 1989 Apr; 28(7):3082-94. PubMed ID: 2742826
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of classical anaphylatoxin as the des-Arg form of the C5a molecule: evidence of a modulator role for the oligosaccharide unit in human des-Arg74-C5a.
    Gerard C; Hugli TE
    Proc Natl Acad Sci U S A; 1981 Mar; 78(3):1833-7. PubMed ID: 6940191
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.